Sheila Scully
Amgen (United States)(US)
Publications by Year
Research Areas
Bone health and treatments, Bone Metabolism and Diseases, Neurogenesis and neuroplasticity mechanisms, NF-κB Signaling Pathways, Regulation of Appetite and Obesity
Most-Cited Works
- → Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation(1998)5,439 cited
- → osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification(1998)2,471 cited
- → Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand(1999)1,635 cited
- → RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism(2000)1,123 cited
- → Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless(1998)880 cited
- → T-cell co-stimulation through B7RP-1 and ICOS(1999)761 cited
- → The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development(2000)750 cited
- → Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice.(1997)669 cited
- → Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis(2000)556 cited
- → Dll4, a novel Notch ligand expressed in arterial endothelium(2000)519 cited